000 01419 a2200397 4500
005 20250513143017.0
264 0 _c19980702
008 199807s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.42.5.1295
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlangaden, G J
245 0 0 _aMechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMay 1998
300 _a1295-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmikacin
_xpharmacology
650 0 4 _aAntitubercular Agents
_xpharmacology
650 0 4 _aDrug Resistance, Multiple
_xgenetics
650 0 4 _aDrug Therapy, Combination
_xpharmacology
650 0 4 _aGenes, Bacterial
_xdrug effects
650 0 4 _aHumans
650 0 4 _aKanamycin
_xpharmacology
650 0 4 _aKanamycin Resistance
_xgenetics
650 0 4 _aMutation
_xgenetics
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
700 1 _aKreiswirth, B N
700 1 _aAouad, A
700 1 _aKhetarpal, M
700 1 _aIgno, F R
700 1 _aMoghazeh, S L
700 1 _aManavathu, E K
700 1 _aLerner, S A
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 42
_gno. 5
_gp. 1295-7
856 4 0 _uhttps://doi.org/10.1128/AAC.42.5.1295
_zAvailable from publisher's website
999 _c9559929
_d9559929